Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

VTRS stock hub

Viatris Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

VTRSis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
20B
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
VTRS
In the news

Latest news · VTRS

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E6.9
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-2
P25 -105.6P50 -46.5P75 -3.1
ROIC5.1
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All VTRS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
265
Groups with data
11
Currency
USD
Showing 265 of 265 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

25
MetricValue
Cik
0001792044
Company name
Viatris Inc.
Country
United States
Country code
US
Cusip
92556V106
Employees
30,000
Employees Change
-2,000%
Employees Change Percent
-6.25
Enterprise value
$32.2B
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
In Index
SP500
Industry
Drug Manufacturers - Specialty & Generic
Isin
US92556V1061
Last refreshed
2026-05-10
Market cap
$20B
Market cap category
Large-Cap
Price
$17.17
Price currency
USD
Rev Per Employee
485,420x
Sector
Healthcare
Sic
2834
Symbol
VTRS
Website
https://www.viatris.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
-1.48%
EV Sales Forward
2.15x
EV/EBIT
23.18x
EV/EBITDA
7.81x
EV/FCF
17.97x
EV/Sales
2.21x
FCF yield
8.97%
Forward P/E
6.92x
P/B ratio
1.36x
P/S ratio
1.37x
PE Ratio10 Y
82.64x
PEG ratio
1.65x
PS Forward
1.34x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

22
MetricValue
EBIT Margin
9.54%
EBITDA Margin
28.33%
FCF margin
12.31%
Gross margin
39.82%
Gross Profit
$5.8B
Gross Profit Growth
-0.43%
Gross Profit Growth Q
11.58%
Gross Profit Growth3 Y
-5.15%
Gross Profit Growth5 Y
1.41%
Net Income
$-296.5M
Net Income Growth Quarters
2%
Net Income Growth Years
0%
Pretax Margin
-5.6%
Profit Margin
-2.04%
Profit Per Employee
$-9,883
ROA
2.31
Roa5y
2.25
ROCE
4.63
ROE
-1.96
Roe5y
-3.98
ROIC
5.07
Roic5y
3.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

26
MetricValue
Cagr10y
-6.08%
Cagr15y
-0.8%
Cagr1y
109.06%
Cagr20y
-0.02%
Cagr3y
28.4%
Cagr5y
8.52%
Div CAGR10
15.87%
Div CAGR3
0%
Div CAGR5
34.27%
EPS Growth Quarters
2
EPS Growth Years
0
FCF Growth
-5.9%
FCF Growth Q
-29.32%
FCF Growth3 Y
-9.22%
FCF Growth5 Y
3.08%
OCF Growth
-2.48%
OCF Growth Q
-27.49%
OCF Growth10 Y
1.76%
OCF Growth3 Y
-8%
OCF Growth5 Y
3.92%
Revenue Growth
1.62x
Revenue Growth Q
8.07x
Revenue Growth Quarters
3x
Revenue Growth Years
0x
Revenue Growth3 Y
-2.68x
Revenue Growth5 Y
1.14x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
$0.39
Assets
$36.8B
Cash
$2.4B
Current Assets
$10.9B
Current Liabilities
$6.8B
Debt
$14.6B
Debt EBITDA
$3.46
Debt Equity
$1
Debt FCF
$8.15
Equity
$14.7B
Interest Coverage
2.92
Liabilities
$22.2B
Long Term Assets
$25.9B
Long Term Liabilities
$15.4B
Net Cash
$-12.2B
Net Cash By Market Cap
$-61.06
Net Debt EBITDA
$2.96
Net Debt Equity
$0.83
Net Debt FCF
$6.81
Tangible Book Value
$-6.5B
Tangible Book Value Per Share
$-5.6
WACC
6.31

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.6
Inventory Turnover
2.18
Net Working Capital
$3.7B
Quick ratio
0.9
Working Capital
$4.1B
Working Capital Turnover
$3.64

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Buyback Yield
2.61%
Dividend Growth
0%
Dividend Growth Years
0%
Dividend per share
$0.48
Dividend Years
6
Dividend Yield
2.8%
Ex Div Date
2026-05-22
Last Dividend
$0.12
Payout Frequency
Quarterly

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

42
MetricValue
10Y total return
-46.57%
1Y total return
108.96%
200-day SMA
12.07
3Y total return
111.72%
50-day SMA
14.26
50-day SMA vs 200-day SMA
50over200
5Y total return
50.46%
All Time High
76.69
All Time High Change
-77.61%
All Time High Date
2015-04-24
All Time Low
0.6
All Time Low Change
2,738.49%
All Time Low Date
1984-05-16
ATR
0.54
Beta
0.87
Beta1y
1.15
Beta2y
1
Ch YTD
37.91
High
17.53
High52
17.53
High52 Date
2026-05-08
High52ch
-2.05%
Low
16.65
Low52
8.19
Low52 Date
2025-05-23
Low52ch
109.65%
Ma50ch
20.38%
Premarket Change Percent
-0.17
Premarket Price
$17.36
Premarket Volume
28,803
Price vs 200-day SMA
42.23%
RSI
79.62
RSI Monthly
69.45
RSI Weekly
74.47
Sharpe ratio
2.26x
Sortino ratio
4.21
Total Return
5.41%
Tr YTD
39.09
Tr15y
-11.36%
Tr1m
30.47%
Tr1w
14.16%
Tr3m
18.77%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

18
MetricValue
Analyst Count
5
Analyst Count Top
2
Analyst Price Target Top
$16
Analyst Ratings
Buy
Analyst Ratings Top
Buy
Earnings EPS Estimate
$0.51
Earnings EPS Estimate Growth
2
Earnings Revenue Estimate
3,355,609,568x
Earnings Revenue Estimate Growth
3.12x
Operating Income
$1.4B
Operating Income Growth
10.41
Operating Income Growth Q
187.5
Operating Income Growth3 Y
-17.95
Operating Income Growth5 Y
3.78
Operating margin
9.54
Price target
$15.4
Price Target Change
$-10.31
Price Target Change Top
$-6.81

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

11
MetricValue
Float
1,154,493,916%
Float Percent
99.14%
Net Borrowing
-1,300,000
Shares Insiders
0.7%
Shares Institutions
86.04%
Shares Out
1,164,552,654
Shares Qo Q
1.97%
Shares Yo Y
-2.61%
Short Float
3.05%
Short Ratio
3.99
Short Shares
3.03

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

71
MetricValue
Adjusted FCF
$1.6B
Average Volume
12,720,349x
Bv Per Share
12.59
CAPEX
$-376.1M
Ch10y
-56.7
Ch15y
-28.16
Ch1m
30.47
Ch1w
14.16
Ch1y
99.65
Ch20y
-20.47
Ch3m
17.76
Ch3y
85.02
Ch5y
21.95
Ch6m
69.66
Change
-1.27%
Change From Open
-0.75
Close
17.39
Days Gap
-0.52
Depreciation Amortization
2,735,800,000
Dollar Volume
347,563,536.1
Earnings Date
2026-05-07
Earnings Time
bmo
EBIT
$1.4B
EBITDA
$4.1B
EPS
$-0.26
F Score
5
FCF
$1.8B
FCF EV Yield
5.57x
FCF Per Share
$1.54
Financing CF
-1,030,700,000
Fiscal Year End
December
Founded
1,961
Goodwill
6,692,400,000
Income Tax
$-518.8M
Investing CF
-85,200,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-05-07
Last Report Date
2026-03-31
Last Split Date
2003-10-09
Last Split Type
Forward
Last10k Filing Date
2026-02-26
Ma150
12.79
Ma150ch
34.29%
Ma20
14.98
Ma20ch
14.63%
Net CF
1,049,400,000
Next Earnings Date
2026-08-06
Open
17.3
Optionable
Yes
P FCF Ratio
11.15
P OCF Ratio
9.22
Payment Date
2026-06-17
Position In Range
59.09
Post Close
17.17
Postmarket Change Percent
-0.83
Postmarket Price
$17.03
Ppne
2,780,900,000
Pre Close
17.39
Price Date
2026-05-08
Price EBITDA
$4.85
Relative Volume
1.59x
Revenue
14,562,600,000x
SBC By Revenue
1.17x
Share Based Comp
170,700,000
Tax By Revenue
-3.56x
Tr20y
-0.39%
Tr6m
73.1%
Us State
Pennsylvania
Volume
20,242,489
Z Score
0.98
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

VTRS dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+2.8%
$0.48 annual per share
Payout ratio
n/a
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+34.3%
0 consecutive years of growth
Total shareholder yield
+5.4%
Next ex-dividend date: 2026-05-22
Performance

VTRS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+109.0%
S&P 500 1Y: n/a
3Y total return
+111.7%
S&P 500 3Y: n/a
5Y total return
+50.5%
S&P 500 5Y: n/a
10Y total return
-46.6%
S&P 500 10Y: n/a
Ownership

Who owns VTRS?

Insider, institutional, and short-interest positioning.

Institutional ownership
+86.0%
Float: +99.1% of shares outstanding
Insider ownership
+0.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+3.1%
4.0 days to cover
Y/Y dilution
-2.6%
Negative means the company is buying back shares.
Technical

VTRS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
79.6
Above 70: short-term overbought
Price vs 200-day MA
+42.2%
50/200-day relationship not available
Beta (5Y)
0.87
Moves roughly with the market
Sharpe ratio
2.26
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About VTRS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current VTRS stock rating?

Viatris Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full VTRS analysis?

The full report lives at /stocks/VTRS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for VTRS?

The latest report frames VTRS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the VTRS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.